GlassScriptPhysician profile
Barbara L Davies
NPI 1245226471
$4,101.61
in general payments reported to CMS, 2019-2025
15 companies · $196 in 2025
The $196 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,520 · 2020: $712 · 2021: $597 · 2022: $345 · 2023: $646 · 2024: $85.25 · 2025: $196.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $923 · Travel and Lodging: $4.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $922.65 |
| Travel and Lodging | $4.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $1,015.11 | 2019-2025 | |
| Allergan, INC. | $976.45 | 2019-2022 | |
| Mentor Worldwide LLC | $768.42 | 2019-2023 | Mentor Memorygel Resterilizable Gel Sizer |
| Galderma Laboratories, L.P. | $631.93 | 2019-2025 | |
| Abbvie INC. | $501.21 | 2023-2025 | Natrelle Saline-Filled Breast Implants |
| Organogenesis INC. | $41.58 | 2022-2023 | Puraply |
| Smith+Nephew, INC. | $30.62 | 2019-2021 | |
| Trevena, INC. | $24.40 | 2021 | |
| Aroa Biosurgery Incorporated | $19.83 | 2020 | |
| Polynovo North America LLC | $19.20 | 2023 | |
| Tela Bio, INC. | $17.86 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Davol INC. | $15.35 | 2025 | Arista |
| Coopersurgical, INC. | $14.70 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $12.69 | 2023 | Seglentis |
| Axogen | $12.26 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barbara Davies listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.